ClinicalTrials.gg
Sign In

Brain Ischemia clinical trials

The registry lists 217 studies for Brain Ischemia across more than 10 countries. 42 are recruiting or about to start. 76 of them are mainly about Brain Ischemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 9 narrower conditions too, such as Ischemic Attack, Transient: 1,130 studies, 311 open.

Get an email when these change. Save the Brain Ischemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
117
Status unknown
31
Recruiting
28
Terminated
21
Not yet recruiting
12
Withdrawn
3

Phase

Phase 3
22
Phase 2
20
Phase 4
11
Phase 1
11
Early Phase 1
1

Where

United States
43
China
26
France
19
Canada
17
Germany
14
Japan
8

Who runs them

University of British Columbia (5) · Gachon University Gil Medical Center (4) · University of Manitoba (3) · Lithuanian University of Health Sciences (3) · China Medical University Hospital (3) · Asan Medical Center (3) · Ludwig-Maximilians - University of Munich (3) · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (3)

What is being tested here

Drugs under test in Brain Ischemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Propofol102
Ticagrelor111
Remifentanil101
Drug Combinations101
Sevoflurane101
Xenon101
Nadroparin101
Albumins101
Butylphthalide101
Tissue Plasminogen Activator024

Drug classes tested here Inhaled anesthetics 2 open · Thrombolytics 9

Coming up

2phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 28 Brain Ischemia studies recruiting now, 19 (68%) set no upper age limit and 3 (11%) stop at 75 or younger. 7 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (11%) take healthy volunteers.

Recruiting studies that take each age, of 28
AgeWomenMen
105 (18%)5 (18%)
1825 (89%)25 (89%)
3025 (89%)25 (89%)
4025 (89%)25 (89%)
5025 (89%)25 (89%)
6526 (93%)26 (93%)
7525 (89%)25 (89%)
8524 (86%)24 (86%)

Across all 217 studies, recruiting or not: 15% stop at 75 or younger and 7% at 65; 13% take children; <1% are for women only and 1% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Brain Ischemia studies take

Of 43 interventional studies with no phase under Brain Ischemia, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase28 mo16–53 · 43 studies——
Observational72 mo36–121 · 36 studies—72 mo36–121 · 34 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 217. Browse all 217 → or search them.